StockWatch
·
Medical/Dental Instruments
Quarterly ResultMay 6, 2026, 06:37 AM

LeMaitre Vascular Q1 Net Sales +11.2% to $66.55M; EPS $0.68

AI Summary

LeMaitre Vascular reported strong financial results for the first quarter of 2026, with net sales increasing by 11.2% and net income surging by 42.4% year-over-year. Diluted earnings per share also saw a substantial rise of 41.7%. The company also increased its cash dividend per common share by 25% to $0.25.

Key Highlights

  • Net sales increased by 11.2% to $66.55 million for Q1 2026, up from $59.87 million in Q1 2025.
  • Net income rose by 42.4% to $15.68 million in Q1 2026, compared to $11.01 million in Q1 2025.
  • Diluted EPS grew by 41.7% to $0.68 in Q1 2026, from $0.48 in the prior year period.
  • Gross profit increased to $48.40 million in Q1 2026 from $41.42 million in Q1 2025.
  • Income from operations was $17.78 million in Q1 2026, a significant increase from $12.63 million in Q1 2025.
  • Cash dividends declared per common share increased by 25% to $0.25 in Q1 2026 from $0.20 in Q1 2025.
  • Net cash provided by operating activities was $15.09 million in Q1 2026, up from $9.04 million in Q1 2025.
  • Total assets stood at $629.53 million as of March 31, 2026, compared to $615.69 million at December 31, 2025.